Ainos, Inc. (OTCMKTS:AIMD – Get Free Report) shares rose 19% during trading on Wednesday . The company traded as high as $0.76 and last traded at $0.73. Approximately 1,120,677 shares changed hands during mid-day trading, a decline of 50% from the average daily volume of 2,224,381 shares. The stock had previously closed at $0.62.
Ainos Stock Up 9.2 %
The company has a market capitalization of $11.25 million, a P/E ratio of -0.92 and a beta of 1.41. The company has a current ratio of 1.92, a quick ratio of 1.45 and a debt-to-equity ratio of 0.08. The stock has a 50 day moving average price of $0.52 and a 200 day moving average price of $0.56.
Ainos Company Profile
Ainos, Inc, a healthcare company, engages in developing medical technologies for point-of-care testing and safe and novel medical treatment for disease indications. The company offers COVID-19 antigen rapid test kit and Ainos' cloud-based test management App, a cloud-based test management platform comprising an antigen rapid test kit, a personal application, and an enterprise app; COVID-19 nucleic acid test; volatile organic compounds point-of-care testing; Very Low-Dose Oral Interferon Alpha, a low-dose oral interferon alpha formulation based IFN-a's broad treatment applications; and Synthetic RNA developing a SRNA technology platform in Taiwan.
See Also
- Five stocks we like better than Ainos
- Learn Technical Analysis Skills to Master the Stock Market
- Why Energy Transfer Stock Could Soar to New Highs in 2025
- Biggest Stock Losers – Today’s Biggest Percentage Decliners
- 3 Buy-and-Hold Stocks for Long-Term Growth
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- Despite Short-Term Risks Freeport McMoran Worth a Look
Receive News & Ratings for Ainos Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ainos and related companies with MarketBeat.com's FREE daily email newsletter.
